Journal
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
Volume 136, Issue 1, Pages 110-115Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejogrb.2006.10.008
Keywords
ovarian cancer; prognostic factors; DNA ploidy; S-phase fraction; cyclin A
Categories
Ask authors/readers for more resources
Objective: To investigate the correlation of DNA ploidy, S-phase fraction (SPF) and the expression of cyclin A to the clinical prognostic factors in patients with epithelial ovarian cancer. Study design: A prospective analysis was performed on 46 ovarian tumor patients. The DNA ploidy and SPF were determined by flow cytometry and the expression of cyclin A was measured by immunohistochemical staining. Results: Compared with benign and borderline tumors, the malignant tumors expressed higher levels of cyclin A (P = 0.007), more aneuploid cells (P = 0.018) and higher SPF (P = 0.015). With regard to DNA ploidy and the clinical prognostic factors, aneuploid cells increased with tumor grade (P = 0.011), the disease stage (P = 0.009) and residual volume (P = 0.001). When residual tumor was more than 2 cm, the expression of cyclin A was increased (P = 0.043). Three-year survival was low for patients with tumors expressing cyclin A in over 10% of cells (P = 0.003). Conclusions: The data suggest that the assessment of the DNA ploidy, SPF and the expression of cyclin A may provide important information for predicting the prognosis of epithelial ovarian cancer. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available